astragaloside a has been researched along with Atherogenesis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 5 (62.50) | 2.80 |
| Authors | Studies |
|---|---|
| Li, WT; Li, YJ; Qin, HW; Wang, Y; Zhang, QS | 1 |
| Gao, ZC; Kang, DF; Kong, XL; Li, C; Li, YL; Liu, XX; Lyu, Q; Wu, JB; Zhang, L; Zhang, YQ | 1 |
| Chen, D; Du, Y; Ye, S; Yu, J | 1 |
| Ding, H; Li, J; Liu, J; Sun, Z; Yan, F; Zhang, W; Zhou, D | 1 |
| Deng, Y; Lin, N; Liu, S; Liu, Z; Shao, X | 1 |
| Dai, RZ; Gao, F; Li, JS; Zhang, DQ; Zhang, YM | 1 |
| Pan, H; Rui, R; Sun, B; Wang, X; Zhang, L | 1 |
| Bian, Y; Chen, J; Chen, L; Chen, Y; Pan, Y; Shen, Y; Song, Z; Wei, D | 1 |
8 other study(ies) available for astragaloside a and Atherogenesis
| Article | Year |
|---|---|
[Molecular mechanism of astragaloside Ⅳ against atherosclerosis by regulating miR-17-5p and PCSK9/VLDLR signal pathway].
Topics: Animals; Atherosclerosis; Lipoproteins, LDL; Mice; MicroRNAs; Proprotein Convertase 9; Receptors, LDL; Saponins; Signal Transduction; Triterpenes | 2022 |
Effect of astragaloside IV and salvianolic acid B on antioxidant stress and vascular endothelial protection in the treatment of atherosclerosis based on metabonomics.
Topics: Antioxidants; Atherosclerosis; Benzofurans; Endothelial Cells; Humans; Methionine; Saponins; Succinic Acid; Triterpenes | 2022 |
Astragaloside IV protects against oxidized low-density lipoprotein-induced injury in human umbilical vein endothelial cells via the histone deacetylase 9 (HDAC9)/NF-κB axis.
Topics: Apoptosis; Atherosclerosis; Histone Deacetylases; Human Umbilical Vein Endothelial Cells; Humans; Lipoproteins, LDL; MicroRNAs; NF-kappa B; NF-KappaB Inhibitor alpha; Oxidative Stress; Repressor Proteins | 2023 |
Glycoside combinations of Buyang Huanwu decoction ameliorate atherosclerosis via STAT3, HIF-1, and VEGF.
Topics: Animals; Atherosclerosis; Endothelial Cells; Glycosides; Hypoxia-Inducible Factor 1; Molecular Docking Simulation; Rats; Vascular Endothelial Growth Factor A | 2023 |
Astragaloside IV alleviates atherosclerosis through targeting circ_0000231/miR-135a-5p/CLIC4 axis in AS cell model in vitro.
Topics: Atherosclerosis; Chloride Channels; Human Umbilical Vein Endothelial Cells; Humans; MicroRNAs; Models, Cardiovascular; RNA, Circular; Saponins; Triterpenes | 2021 |
Astragaloside IV inhibits Angiotensin II-stimulated proliferation of rat vascular smooth muscle cells via the regulation of CDK2 activity.
Topics: Angiotensin II; Animals; Atherosclerosis; Cell Line; Cyclin-Dependent Kinase 2; G1 Phase; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; S Phase; Saponins; Triterpenes; Vascular Remodeling | 2018 |
Effect of Combined Use of Astragaloside IV (AsIV) and Atorvastatin (AV) on Expression of PPAR-γ and Inflammation-Associated Cytokines in Atherosclerosis Rats.
Topics: Animals; Atherosclerosis; Atorvastatin; China; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Inflammation; Interleukin-18; Interleukin-6; Lipoproteins, HDL; Lipoproteins, LDL; Male; PPAR gamma; Rats; Rats, Sprague-Dawley; Saponins; Signal Transduction; Triterpenes; Tumor Necrosis Factor-alpha | 2018 |
Association of astragaloside IV-inhibited autophagy and mineralization in vascular smooth muscle cells with lncRNA H19 and DUSP5-mediated ERK signaling.
Topics: Animals; Atherosclerosis; Autophagy; Autophagy-Related Proteins; Cells, Cultured; Disease Models, Animal; Dual-Specificity Phosphatases; Extracellular Signal-Regulated MAP Kinases; Humans; Mice, Inbred C57BL; Mice, Knockout, ApoE; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Plaque, Atherosclerotic; RNA, Long Noncoding; Saponins; Signal Transduction; TOR Serine-Threonine Kinases; Triterpenes; Vascular Calcification | 2019 |